Ventyx Stock Based Compensation from 2010 to 2025

VTYX Stock

USD 2.01 0.04 1.95%

Ventyx Biosciences Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2025. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2010-12-31

Previous Quarter

32.9 M

Current Value

34.5 M

Quarterly Volatility

12.9 M

Credit Downgrade

Yuan Drop

Covid

Check Ventyx Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ventyx Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 17.7 M, Depreciation And Amortization of 135.1 K or Interest Expense of 5.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.56. Ventyx financial statements analysis is a perfect complement when working with Ventyx Biosciences Valuation or Volatility modules.

Check out the analysis of Ventyx Biosciences Correlation against competitors.

For more information on how to buy Ventyx Stock please use our How to Invest in Ventyx Biosciences guide.

Latest Ventyx Biosciences' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Ventyx Biosciences over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Ventyx Biosciences' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ventyx Biosciences' overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Ventyx Stock Based Compensation Regression Statistics

	Arithmetic Mean	7,331,826
	Geometric Mean	727,203
	Coefficient Of Variation	176.51
	Mean Deviation	10,403,363
	Median	198,000
	Standard Deviation	12,941,073
	Sample Variance	167.5T
	Range	34.5M
	R-Value	0.77
	Mean Square Error	74.1T
	R-Squared	0.59
	Significance	0.0005
	Slope	2,082,711
	Total Sum of Squares	2512.1T

Ventyx Stock Based Compensation History

	2025	34.5 M
	2024	32.9 M
	2023	28.6 M
	2022	16.6 M
	2021	2.7 M
	2020	45 K

Other Fundumenentals of Ventyx Biosciences

Stock Based Compensation To Revenue

Ventyx Biosciences Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Net Receivables	Capital Surpluse	Common Stock	Property Plant Equipment	Short Term Debt
Total Assets		0.21	0.76	-0.95	-0.86	0.99	0.86	0.68	1.0	1.0	1.0	0.62	0.84	0.8	0.84	0.61
Total Stockholder Equity	0.21		0.6	-0.06	-0.66	0.31	0.23	0.56	0.18	0.24	0.22	0.89	0.54	0.63	0.53	0.86
Net Tangible Assets	0.76	0.6		-0.6	-0.93	0.81	0.62	0.72	0.74	0.77	0.76	0.87	0.95	0.96	0.95	0.81
Net Debt	-0.95	-0.06	-0.6		0.73	-0.91	-0.76	-0.5	-0.97	-0.95	-0.95	-0.46	-0.65	-0.62	-0.66	-0.42
Retained Earnings	-0.86	-0.66	-0.93	0.73		-0.9	-0.78	-0.83	-0.83	-0.87	-0.86	-0.92	-0.93	-0.93	-0.93	-0.87
Accounts Payable	0.99	0.31	0.81	-0.91	-0.9		0.89	0.78	0.98	0.99	0.99	0.69	0.89	0.85	0.9	0.69
Long Term Debt	0.86	0.23	0.62	-0.76	-0.78	0.89		0.9	0.83	0.86	0.86	0.57	0.74	0.7	0.74	0.6
Total Liab	0.68	0.56	0.72	-0.5	-0.83	0.78	0.9		0.64	0.7	0.69	0.76	0.8	0.79	0.8	0.79
Net Invested Capital	1.0	0.18	0.74	-0.97	-0.83	0.98	0.83	0.64		1.0	1.0	0.58	0.82	0.77	0.82	0.58
Total Current Assets	1.0	0.24	0.77	-0.95	-0.87	0.99	0.86	0.7	1.0		1.0	0.64	0.85	0.81	0.85	0.64
Net Working Capital	1.0	0.22	0.76	-0.95	-0.86	0.99	0.86	0.69	1.0	1.0		0.62	0.84	0.8	0.85	0.62
Net Receivables	0.62	0.89	0.87	-0.46	-0.92	0.69	0.57	0.76	0.58	0.64	0.62		0.83	0.89	0.82	0.95
Capital Surpluse	0.84	0.54	0.95	-0.65	-0.93	0.89	0.74	0.8	0.82	0.85	0.84	0.83		0.98	1.0	0.86
Common Stock	0.8	0.63	0.96	-0.62	-0.93	0.85	0.7	0.79	0.77	0.81	0.8	0.89	0.98		0.98	0.91
Property Plant Equipment	0.84	0.53	0.95	-0.66	-0.93	0.9	0.74	0.8	0.82	0.85	0.85	0.82	1.0	0.98		0.85
Short Term Debt	0.61	0.86	0.81	-0.42	-0.87	0.69	0.6	0.79	0.58	0.64	0.62	0.95	0.86	0.91	0.85

Click cells to compare fundamentals

About Ventyx Biosciences Financial Statements

Ventyx Biosciences investors use historical fundamental indicators, such as Ventyx Biosciences' Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Ventyx Biosciences. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Stock Based Compensation	32.9 M	34.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation

Additional Tools for Ventyx Stock Analysis

When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ventyx Stock Based Compensation from 2010 to 2025

Latest Ventyx Biosciences' Stock Based Compensation Growth Pattern

Ventyx Stock Based Compensation Regression Statistics

Ventyx Stock Based Compensation History

Other Fundumenentals of Ventyx Biosciences

Ventyx Biosciences Stock Based Compensation component correlations

About Ventyx Biosciences Financial Statements

Also Currently Popular

Additional Tools for Ventyx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY